Pharmaceutical Benefits Regulations (Cth)

STATUTORY RULES.

1948. No..

REGULATIONS UNDER THE PHARMACEUTICAL BENEFITS ACT 1947*

I, THE GOVERNOR-GENERAL in and over the Commonwealthof Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulation under the Pharmaceutical Benefits Act 1947.

Dated this seventh day of May, 1948.

W.J. McKell

Governor-General.

By His Excellency’s Command,

  

Minister of State for Health

 

PHARMACEUTICAL BENEFITS REGULATIONS.*

Citation.

1. These Regulations may be cited as the Pharmaceutical Benefits Regulations.

Definitions.

2.— (1.) In these Regulations, unless the contrary intention appears—

“approved hospital” means a public hospital the governing body of which, or a private hospital the proprietor of which, is an approved hospital authority;

“authorized person”means a person authorized to act under section 21 of the Act, and includes such a person when acting otherwise than in pursuance of that section;

“prescription” means a prescription in accordance with Form E written by a medical practitioner, and includes the duplicate copy of a prescription;

“the Act” means the Pharmaceutical Benefits Act 1947.

(2.) For the purposes of the Schedules to these Regulations, unless the contrary intention appears—

(a) the Australian Capital Territory (including the Jervis Bay Territory) shall be deemed to be part of the State of New South Wales; and

(b)the Northern Territory shall be deemed to be part of the State of South Australia.

(3.) For the purposes of the Act and of these Regulations, the hospitals which shall be deemed to be public hospitals shall be hospitals which—

(a)are ordinarily recognized as public hospitals; and

(b)in the case of hospitals situated in a State, are in receipt of a grant for maintenance from the State.

* Notified in the Commonwealth Gazette on  , 1948.

6317/45.—PRICE 3s.  30/5.5.1948.

Forms.

3. In these Regulations, any reference to a form shall be read as a reference to a form in the First Schedule to these Regulations.

Pharmaceutical Formulary and Addendum.

4.— (1.) The Commonwealth Pharmaceutical Formulary shall be in accordance with the Second Schedule to these Regulations,

(2.) The addendum to the Commonwealth Pharmaceutical Formulary shall be in accordance with the Third Schedule to these Regulations.

(3.) Except in the case of formulae required to conform to the standards prescribed by the British Pharmacopoeia, the British Pharmaceutical Codex or the Australian Pharmaceutical Formulary, and biological products, capsules of amyl nitrite, injections (other than rectal injections), pills, tablets for oral or hypodermic administration, vitamin solutions, a formula in the Commonwealth Pharmaceutical Formulary may be varied—

(a)by reducing the quantity of any ingredient;

(b)by omitting any ingredient;

(c)by adding any drug (other than a drug included in the formula) specified in the Commonwealth Pharmaceutical Formulary in any list of allowable additions applicable to the formula; or

(d)by increasing the quantity of any ingredient marked with an asterisk up to the maximum British Pharmacopoeia dose for that ingredient.

(4.) An ointment base in the Commonwealth Pharmaceutical Formulary may be appropriately varied in a region where the prevailing temperature renders the formula for that base unsuitable.

Application for approval as a pharmaceutical chemist or hospital authority.

5. An application by a pharmaceutical chemist or a hospital authority to be approved for the purposes of the Act shall be in accordance with Form A, Form B or Form C, whichever is appropriate.

Sign to be displayed by approved pharmaceutical chemists.

6.—(1.) The sign to be displayed by an approved pharmaceutical chemist shall be in accordance with the form in the Fourth Schedule to these Regulations.

(2.) The sign shall be affixed in some conspicuous place in or on each of the premises (not being premises in respect of which a limited approval is in force) in respect of which the pharmaceutical chemist is approved in such manner as to be readily visible to persons entering the premises.

(3.) An approved pharmaceutical chemist shall at all times keep prominently displayed, in such manner as to be readily visible to persons seeking to enter the premises, at each of the premises in respect of which the pharmaceutical chemist is approved, a notice in accordance with Form D setting out the hours during which services for the supply of pharmaceutical benefits are available.

Revocation of approval of medical practitioner.

7. If it is shown to the Director-General that the approval of a medical practitioner under section eleven of the Act is, or will be, no longer necessary by reason of the fact that a pharmaceutical chemist

is, or is about to be, approved in respect of premises in the area in relation to which the approval of the medical practitioner was granted, the Director-General may revoke the approval of the medical practitioner as from a date specified in the notice of the revocation, being a date after which, in the opinion of the Director-General, the approval will no longer be necessary.

Suspension or revocation of approval by the Director-General.

8.—(1.) Except in cases to which the last preceding regulation applies, before suspending or revoking, under sub-section (1.) of section 13 of the Act, the approval of a pharmaceutical chemist, medical practitioner or hospital authority, the Director-General shall give to the Pharmaceutical chemist, medical practitioner or hospital authority a notice specifying the grounds of the proposed suspension or revocation and shall refer the matter to a Pharmaceutical Benefits Committee for inquiry and report to the Director-General.

(2.) Any inquiry under this regulation shall be conducted by the Pharmaceutical Benefits Committee in such manner as the Director-General directs.

(3.) The approved pharmaceutical chemist, medical practitioner or hospital authority shall be entitled to attend the inquiry and be heard by the Committee.

Notice of suspension or revocation.

9. Where the Director-General suspends or revokes the approval of a pharmaceutical chemist, medical practitioner or hospital authority, the Director-General shall serve notice of the suspension or revocation to the pharmaceutical chemist, medical practitioner or hospital authority concerned, and the suspension or revocation shall not take effect before service of the notice has been effected.

Forms, &c., to be delivered up when approval suspended or revoked.

10. Where the approval of a pharmaceutical chemist, medical practitioner or hospital authority has been suspended or revoked, the pharmaceutical chemist, medical practitioner or hospital authority—

(a) shall, if the Director-General so requires, deliver up to the Director-General all documents and forms supplied to him or it by the Commonwealth with respect to the provision of pharmaceutical benefits, other than documents or forms which he has parted with in accordance with the Act and these Regulations; and

(b)shall not display any sign indicating that he or it has been, or is, approved to supply pharmaceutical benefits under the Act.

Penalty: Fifty pounds.

Prescriptions.

11.—(1.) A prescription for the supply of a pharmaceutical benefit shall be in accordance with Form E, and shall indicate by the use of the relevant title included in the Commonwealth Pharmaceutical Formulary or the addendum thereto the name of the pharmaceutical benefit to be supplied.

(2.) Subject to this regulation, each prescription shall be written in duplicate on a form supplied by the Commonwealth, and one prescription only shall be written on each prescription form.

(8.) A medical practitioner shall not use a prescription form supplied by the Commonwealth otherwise than for the writing of a prescription in accordance with, and for the purposes of, the Act and these Regulations.

Penalty: Fifty pounds.

817/49.—35

(4.) A medical practitioner shall not write a prescription for the supply of a pharmaceutical benefit unless—

(a) he has satisfied himself by personal examination of the person in respect of whom the prescription is written that the pharmaceutical benefit specified in the prescription is necessary for the treatment of that person;

(b)that person is suffering from a recurrent, chronic or malignant disease and has previously been under treatment for that disease by the medical practitioner; or

(c) it is impracticable for the medical practitioner to examine that person, and adequate particulars of the person’s physical condition have been communicated to him.

(5.) Where, in a case of emergency, a medical practitioner considers it necessary to write a prescription for the supply of a pharmaceutical benefit, but a prescription form supplied by the Commonwealth is not immediately available for that purpose, he may write a prescription in accordance with Form E on any other suitable paper, and in any such case the provisions of sub-regulation (2.) of this regulation shall not apply.

(6.) Where a pharmaceutical chemist has supplied a pharmaceutical benefit on presentation of a prescription written by a medical practitioner in accordance with the last preceding sub-regulation, the pharmaceutical chemist—

(a)shall, as soon as is practicable, request the medical practitioner to furnish to the pharmaceutical chemist, in lieu of that prescription, a separate prescription, in duplicate, on a form supplied by the Commonwealth in respect of each pharmaceutical benefit included in the first-mentioned prescription; and

(b)subject to this regulation, shall not be entitled to receive payment from the Commonwealth in respect of that pharmaceutical benefit unless he has obtained, and produces with his claim for payment, such a separate prescription.

(7.) A medical practitioner to whom a request has been made under the last preceding sub-regulation shall, within two days after the making of the request, comply with the request.

Penalty: Fifty pounds.

(8.) If the Director-General is satisfied that the pharmaceutical chemist has been unable to obtain from the medical practitioner a prescription in accordance with sub-regulation (6.) of this regulation, he shall, upon a claim for payment being made by the pharmaceutical chemist not earlier than one month after he has requested the medical practitioner to furnish such a prescription, direct that production of such a prescription shall not be necessary, and thereupon production of such a prescription shall not be required as a condition of payment for the supply of the pharmaceutical benefit.

(9.) A medical practitioner who writes a prescription for a pharmaceutical benefit otherwise than on a form supplied by the Commonwealth shall not write on the prescription a direction that the

pharmaceutical benefit be supplied more than once, and if he does write such a direction, the prescription shall be deemed, for the purposes of the Act and these Regulations, to be a prescription for the supply of the pharmaceutical benefit once only.

(10.) Subject to these Regulations, a medical practitioner shall not give or send or cause or permit to be given or sent to any person a form in accordance with Form E (whether signed by him or not) unless he has first written on the form, in accordance with these Regulations, a prescription for the supply of a pharmaceutical benefit.

Penalty: Fifty pounds.

Benefits to be supplied on surrender of prescription or direction of hospital authority.

12.— (1.) A person shall not be entitled to receive a pharmaceutical benefit in pursuance of the Act from an approved hospital authority in or at a hospital unless—

(a)he is registered as a patient of that hospital; and

(b)the supply of the benefit is directed or made by a person authorized in that behalf by the hospital authority.

(2.) A person shall not be entitled to receive a pharmaceutical benefit under the Act from an approved hospital authority being the proprietor of a private hospital at which a pharmaceutical chemist is employed, or from an approved medical practitioner, except on presentation of a prescription.

(3.) A person who seeks to obtain a pharmaceutical benefit upon presentation of ‘a prescription shall not be entitled to receive that pharmaceutical benefit unless he surrenders that prescription to the person supplying the pharmaceutical benefit.

(4.) An approved pharmaceutical chemist who, or an approved hospital authority which, supplies a pharmaceutical benefit on presentation of a prescription shall indicate the fact by a stamp or signature on the back of the prescription.

Special charges.

13.— (1.) Subject to the next succeeding sub-regulation, where a prescription is presented to an approved pharmaceutical chemist at any time other than within usual trading hours, the pharmaceutical chemist shall be entitled to make a special charge of One shilling, and to refuse to supply the pharmaceutical benefit unless the special charge is paid by or on behalf of the person to whom the pharmaceutical benefit is to be supplied.

(2.) Where two or more prescriptions are so presented at the same time for the same person, the pharmaceutical chemist shall be entitled to make a special charge of One shilling only.

(3.) Where any pharmaceutical benefit is delivered otherwise than at the place where the approved pharmaceutical chemist or medical practitioner carries on his business or practice, the pharmaceutical chemist or medical practitioner shall be entitled to make a special charge equal to the cost of delivery, and to refuse to supply the pharmaceutical benefit unless the special charge is paid by or on behalf of the person to whom the pharmaceutical benefit is to be supplied.

Validity of prescriptions.

14. A statement required under sub-section (3.) of section 8 of the Act by an approved pharmaceutical chemist who suspects that a prescription has not been signed by a medical practitioner or has been forged or fraudulently obtained shall be in accordance with Form F.

Repeated prescription.

15.—(1.) Except as provided in these Regulations, a medical practitioner shall not, in a prescription, direct that a pharmaceutical benefit is to be supplied more than once, and a person shall not be entitled to receive a pharmaceutical benefit more than once on a prescription which is written contrary to this regulation.

(2.) Subject to these Regulations, a medical practitioner may direct that a prescription be repeated a number of times not exceeding the number specified in the following table opposite to the class of prescription, but the quantity or number ordered to be supplied on the first occasion shall be the maximum quantity or number specified in the Commonwealth Pharmaceutical Formulary:—

Class of Prescription.	Number of Repeats (in addition to first supply).
1. General Section.
Creams....................................................................................................................	2
Dusting powders......................................................................................................	2
Ear drops.................................................................................................................	1
Elixirs......................................................................................................................	1
Eye drops................................................................................................................	1
Eye lotions..............................................................................................................	1
Gargles and mouth washes.......................................................................................	1
Gelatins...................................................................................................................	3
Glycanths................................................................................................................	1
Inhalations...............................................................................................................	1
Insufflations............................................................................................................	1
Irrigations................................................................................................................	2
Linctuses.................................................................................................................	1
Liniments................................................................................................................	2
Lotions....................................................................................................................	2
Mixtures..................................................................................................................	3
Nasal drops.............................................................................................................	2
Ointments................................................................................................................	2
Paints......................................................................................................................	1
Pastes......................................................................................................................	2
Pessaries..................................................................................................................	2
Pills.........................................................................................................................	1
Powders..................................................................................................................	2
Soaps......................................................................................................................	1
Solutions for internal use..........................................................................................	2
Sprays.....................................................................................................................	2
Suppositories...........................................................................................................	1
Syrups.....................................................................................................................	1
Tablets....................................................................................................................	1
2. Children’s Section.
Linctuses.................................................................................................................	1
Mixtures..................................................................................................................	3
Syrups.....................................................................................................................	3
Vitamin solutions.....................................................................................................	2
3. Biological Products.
Thyroid gland tablets................................................................................................	1

(3.) Where a prescription directs that a pharmaceutical benefit is to be supplied more than once, that pharmaceutical benefit shall not be supplied (whether by the same supplier or by different suppliers) more than once on any one day.

(4.) Except in the case of a prescription to which is attached a certificate issued under regulation 17 of these Regulations, where a prescription directs that a pharmaceutical benefit is

to be supplied more than once, and the pharmaceutical benefit has been supplied once, the number of subsequent occasions on which the pharmaceutical benefit may be supplied and received shall, at the end of each period of twenty-one days after the first supply, be the original number of subsequent occasions specified in the prescription in accordance with these Regulations, reduced by the total of—

(a)a number equal to the number of such periods of twenty-one days which have elapsed; and

(b)a number equal to the number of occasions in excess of one on which the pharmaceutical benefit has been supplied during any such period of twenty-one days.

(5.) An approved pharmaceutical chemist who supplies a pharmaceutical benefit on presentation of—

(a)a prescription which contains a direction to supply that pharmaceutical benefit more than once; or

(b)a repeat authorization issued in accordance with this sub-regulation, shall, unless no further supply of the pharmaceutical benefit (after the supply which ho is making) is authorized, issue to the person presenting the prescription or repeat authorization a repeat authorization in a form supplied by the Commonwealth, and shall attach the duplicate of the prescription to the repeat authorization.

(6.) For the purpose of entitling a person to the supply of a pharmaceutical benefit, presentation of the duplicate of a prescription shall be deemed to be presentation and surrender of a prescription if, and only if—

(a)there is attached to that duplicate a repeat authorization, referring to the prescription by its number, which indicates that the pharmaceutical benefit specified in the duplicate prescription has not been supplied for the full number of times authorized by the prescription and these Regulations; and

(b)the person obtaining the pharmaceutical benefit signs a receipt in accordance with Form G for the pharmaceutical benefit on the back of a repeat authorization and surrenders the repeat authorization to the person supplying the pharmaceutical benefit.

(7.) An approved pharmaceutical chemist or medical practitioner who supplies pharmaceutical benefits on presentation of a repeat authorization shall indicate the fact by a stamp or signature on the back of the repeat authorization.

Maximum quantities.

16.—(1.) Subject to this regulation and to the next succeeding regulation, the sign + used in relation to any formula in the Commonwealth Pharmaceutical Formulary, or in relation to any item in the addendum to the Commonwealth Pharmaceutical Formulary, indicates the maximum quantity or number which may be prescribed for supply, or supplied, at any one time.

(2.) In the case of mixtures (not being mixtures included in the section headed “2. Children’s Section” of the Commonwealth Pharmaceutical Formulary), double the maximum quantity indicated by the sign + may be prescribed, and supplied, where persons in outlying districts have difficulty in obtaining supplies, but such a prescription shall not provide for more than one repeat.

(3.) A person shall not be entitled to obtain a pharmaceutical benefit being an insulin syringe unless he furnishes to the person supplying the pharmaceutical benefit a statement declaring that—

(a)he is receiving insulin treatment, and does not possess a hypodermic syringe suitable for the purpose of that treatment; and

(b)he has not been supplied, by virtue of the Act, with a hypodermic syringe, suitable for the injection of insulin, at any time during the period of six months immediately preceding the date of the prescription.

Recurrent, chronic and malignant cases.

17.—(1.) Where a medical practitioner considers it necessary for the treatment of a person suffering from a recurrent, chronic or malignant disease to direct in a prescription that a pharmaceutical benefit (not being a pharmaceutical benefit contained in the section headed “2. Children’s Section” of the Commonwealth Pharmaceutical Formulary) is to be supplied a greater number of times than the number otherwise permitted by these Regulations, he may issue in duplicate a certificate in accordance with Form H and may thereupon include in a prescription a direction that the supply of the pharmaceutical benefit is to be repeated in accordance with the certificate.

(2.) The maximum period of weeks which may be stated in a certificate in accordance with Form H shall be thirteen weeks.

(3.) A person shall not be entitled to obtain a pharmaceutical benefit on presentation of a prescription which refers to a certificate in accordance with Form H if—

(a) a period equal to, or greater than, the period of treatment stated in the certificate has elapsed since the date of the prescription; or

(b)the estimated total quantity or number of doses stated in the certificate has already been obtained.

(4.) A person shall not be entitled to receive a pharmaceutical benefit on presentation of a prescription which directs that the pharmaceutical benefit is to be supplied more than the number of times allowable apart from this regulation unless—

(a) where a pharmaceutical benefit has not previously been supplied in respect of the prescription—he also presents a certificate in duplicate in accordance with Form H relating to the prescription; or

(b)where a pharmaceutical benefit has previously been supplied in respect of the prescription—he also presents the original of a certificate in accordance with Form H relating to the prescription.

(5.) In any case to which paragraph (a)of the last preceding sub-regulation applies, the person obtaining the pharmaceutical benefit shall surrender to the person supplying the pharmaceutical benefit the duplicate of the certificate.

(6.) Where a pharmaceutical benefit, in respect of which a certificate is issued in pursuance of this regulation, is a mixture, the maximum quantity of which (indicated by the sign + in the Commonwealth Pharmaceutical Formulary) does not exceed eight fluid ounces, the quantity which shall be prescribed for supply, and supplied on each supply, shall be double that maximum quantity, but the quantity

supplied at the last supply shall be not more than the quantity required to complete the total number of doses, or total quantity, specified in the certificate.

Time at which prescriptions may be presented to chemist.

18.—(1.) Except as provided in this regulation, a person shall not be entitled to receive a pharmaceutical benefit from an approved pharmaceutical chemist except during the usual trading hours of that pharmaceutical chemist.

(2.) A prescription for the supply of a pharmaceutical benefit, being a prescription marked with the word “urgent” and having the marking initialled by the medical practitioner may be presented at any hour to an approved pharmaceutical chemist at the premises in respect of which he is approved, and, subject to the Act and these Regulations, the pharmaceutical chemist shall supply the pharmaceutical benefit as soon as is practicable.

Rebates, &c., not allowed.

19.—(1.) An approved pharmaceutical chemist shall not give, promise or offer any gift, rebate or reward as an inducement to a person to present, or in consideration of a person’s presenting, a prescription for the supply of a pharmaceutical benefit.

(2.) Subject to these Regulations, a pharmaceutical chemist to whom a prescription is presented shall not—

(a)supply any other drug, medicine, medicinal compound, medical material or appliance in lieu of the pharmaceutical benefit specified in the prescription; or

(b)make any payment in money or give any other consideration to the person presenting the prescription in exchange for the prescription.

Penalty: Fifty pounds.

Supervision of dispensing.

20. An approved pharmaceutical chemist, approved medical practitioner or approved hospital authority shall not permit a person other than a registered pharmacist or pharmaceutical chemist, or a medical practitioner, to dispense any pharmaceutical benefit for the purposes of the Act except under the direct supervision of a registered pharmacist or pharmaceutical chemist or of a medical practitioner.

Penalty: Fifty pounds.

Names, &c., of dispensers to be supplied.

21. An approved pharmaceutical chemist, approved medical practitioner or approved hospital authority shall, if so required by the Director-General, furnish to the Director-General the names, and particulars of the qualifications, of all persons employed by him or it in dispensing pharmaceutical benefits for the purposes of the Act.

Penalty: Fifty pounds.

Proper stocks to be kept.

22. An approved pharmaceutical chemist shall, as far as practicable, keep in stock an adequate supply of all drugs and other materials which may reasonably be expected to be required for the supply of pharmaceutical benefits.

Acts required to be done by a medical practitioner who supplies pharmaceutical benefits.

23.—(1.) Subject to these Regulations, where a medical practitioner has been approved under section 11 of the Act, that medical practitioner shall do the acts and things which are required to be done by an approved pharmaceutical chemist in accordance with the Act and these Regulations unless the Director-General otherwise directs in respect of any one or more of those acts and things.

(2.) Where a person obtains a pharmaceutical, benefit from a medical practitioner, that person shall give a receipt for the pharmaceutical benefit.

Medical practitioner not to dispense repeats.

24. An approved medical practitioner who has included in a prescription a direction to repeat the prescription shall not himself supply more than once the pharmaceutical benefit specified therein.

Formulary Committee.

25. The Formulary Committee appointed under section 18 of the Act shall advise the Minister on any matter in connexion with the Commonwealth Pharmaceutical Formulary or the addendum to the Commonwealth Pharmaceutical Formulary which the Minister refers to the Committee for consideration or upon which the Committee considers it desirable to offer advice to the Minister.

Payment for attending meetings of Formulary Committee, &c.

26.— (1.) Every member of the Formulary Committee (other than the Director-General or an employee of the Commonwealth) shall be paid a fee of Five pounds five shillings, and every member of a Pharmaceutical Benefits Committee (other than an employee of the Commonwealth) shall be paid a fee of Three pounds three shillings, for each day on which he attends a meeting of the Committee.

(2.) Where any such member resides at a distance of more than fifty miles from the place where a meeting of the Committee is held, he shall, subject to this regulation, be paid an allowance at the rate of Two pounds two shillings per day to cover expenses incurred in travelling in connexion with attendance at that meeting.

(3.) An allowance shall not be payable under the last preceding sub-regulation in respect of any day for which the member is paid a fee for attendance at a meeting of a Committee.

(4.) In addition to the allowance specified in sub-regulation (2.) of this regulation, a member shall be reimbursed the fares actually and necessarily incurred in travelling from his place of residence to the place where the meeting is held and in returning to his place of residence.

Payment for samples.

27. Where a sample is taken under section 21 of the Act, the Commonwealth shall make payment therefor—

(a)in the case of a pharmaceutical benefit—at the rate specified for that pharmaceutical benefit in the Fifth Schedule to these Regulations;

(b)in the case of an ingredient of a pharmaceutical benefit— at the prevailing retail price for the drug, medicine, substance or material.

Treatment of samples.

28.—(1.) Where an authorized person has—

(a) taken a sample of a drug, medicine or substance which may be supplied as, or may be an ingredient of, a pharmaceutical benefit; or

(b)on presentation of a prescription for a pharmaceutical benefit, obtained a pharmaceutical benefit,

with the intention of submitting the sample or the pharmaceutical benefit to analysis or examination, he shall thereupon notify the person from whom he obtained the sample or the pharmaceutical benefit of that intention.

(2.) Subject to sub-regulation (4.) of this regulation, the authorized person shall, in the presence of the person from whom he obtained the sample or the pharmaceutical benefit, divide the sample or pharmaceutical benefit into three parts and shall suitably seal and label each part.

(3.) The authorized person shall then deliver one of the parts to the person from whom he obtained the sample or pharmaceutical benefit, and may submit one of the other two parts for analysis or examination by an analyst appointed by the Director-General.

(4.) Where a sample or pharmaceutical benefit is a medical appliance or medical material, or is contained in an ampoule, it shall not be divided, and the authorized person taking the sample or pharmaceutical benefit shall suitably seal or fasten and label the sample or pharmaceutical benefit.

(5.) The authorized person may submit the whole of any such sample to an analyst appointed by the Director-General.

(6.) A certificate given by an analyst appointed by the Director-general shall be in accordance with Form I.

(7.) Where an analyst has reported that the standard of composition or purity of a sample taken in accordance with these Regulations, or of a pharmaceutical benefit obtained by an authorized person, is not in accordance with the standard prescribed in the Commonwealth Pharmaceutical Formulary or does not conform to the standards prescribed by the law of the State or Territory of the Commonwealth in which the sample or pharmaceutical benefit was obtained, or is not in accordance with the prescription, the Director-General—

(a) shall inform the approved pharmaceutical chemist or approved hospital authority concerned accordingly;

(b)may submit the part retained in accordance with sub-regulation (3.) of this regulation to some other analyst; and

(c)may warn that pharmaceutical chemist or hospital authority that he may require that pharmaceutical chemist or hospital authority to show cause why the approval of that pharmaceutical chemist or hospital authority in respect of the premises or hospital at which the sample was taken, or the pharmaceutical benefit was obtained, should not be revoked or suspended.

Obstructing an authorized portion an offence.

29. A person shall not obstruct any authorized person in the execution of his powers under section 21 of the Act.

Penalty: Fifty pounds.

Claims for payment.

30.— (1.) Claims for payment in respect of the supply of pharmaceutical benefits shall be in accordance with a form approved by the Director-General.

(2.) A claim for payment made in accordance with the last preceding sub-regulation shall be furnished to the Department of Health at such place as the Director-General specifies.

(3.) Except where the Director-General, in special circumstances, otherwise directs, an approved pharmaceutical chemist or an approved medical practitioner, or an approved hospital authority who is the proprietor of a private hospital at which a pharmaceutical chemist is

employed, shall not be entitled to payment in respect of the supply of a pharmaceutical benefit referred to in any such claim unless the claim is accompanied by—

(a)the original of the prescription, or of the repeat authorization, upon presentation and surrender of which the pharmaceutical benefit was supplied; and

(b)where the pharmaceutical benefit was supplied in circumstances in which the person obtaining the benefit was required to furnish a statement in accordance with Form F or regulation 16, or the duplicate of a certificate in accordance with Form H—that certificate or duplicate.

(4.) An approved pharmaceutical chemist, approved medical practitioner or approved hospital authority shall not be entitled to receive payment in respect of the supply of a pharmaceutical benefit which has been supplied otherwise than in accordance with these Regulations, or has been obtained by a person other than a person appearing to be entitled to receive it.

(5.) Where any item in any claim for payment has been disallowed in whole or in part, the Director-General may give to the claimant, or to a member of a Pharmaceutical Benefits Committee acting on behalf of the claimant, reasonable facilities for examining the prescriptions and repeat authorizations relating to the disallowed item which accompanied the claim and also for examining the computations made by the Department of Health in connexion with the claim.

Pharmaceutical tariff.

31.— (1.) Rates of payment to pharmaceutical chemists and to medical practitioners in respect of the supply of pharmaceutical benefits in accordance with the provisions of the Act and of these Regulations shall be in accordance with the Fifth Schedule to these Regulations.

(2.) The person to whom a prescription for the supply of a pharmaceutical benefit is presented shall not be bound to supply the pharmaceutical benefit in the form of a particular trade mark, brand, make, or proprietary equivalent of that pharmaceutical benefit (whether specified in the prescription or not), and, if he does supply the pharmaceutical benefit in such a form, the rate of payment to be made by the Commonwealth shall nevertheless be the rate for that pharmaceutical benefit ascertained in accordance with these Regulations.

Payments to Approved hospital authorities.

32.—(1.) Payments under sub-section (3.) of section 14 of the Act shall be in accordance with this regulation.

(2.) Where the Director-General is satisfied that adequate provision of pharmaceutical benefits in accordance with the Act has been made, during any period, by an approved hospital authority at a public hospital in respect of which the authority was approved, the approved hospital authority shall be entitled to payment from the Commonwealth at the rate, or on the basis, determined by the Treasurer from time to time, in accordance with this regulation, as the rate or basis applicable to public hospitals in the State or Territory in which the public hospital is situated.

(3.) The rate or basis shall, in the case of public hospitals situated in a State, be determined by the Treasurer after consultation with the Treasurer of that State, and shall be a rate or basis which, in the opinion of the Treasurer, will result in payments covering as nearly as

practicable the cost, to approved public hospitals in the State or Territory concerned, of supplying the pharmaceutical benefits in respect of which the payments are made.

(4.) A determination under this regulation shall—

(a)be published in the Gazette;

(b) come into force on a date specified in the determination, not being earlier than the date of publication; and

(c)be applicable to the supply of pharmaceutical benefits from and including the date on which the determination comes into force to and including the date preceding the date on which a determination superseding that determination comes into force.

(5.) The Director-General may authorize payment in advance of any amount which he considers is likely to become payable to an approved hospital authority in accordance with sub-regulation (2.) of this regulation in respect of any period, and in any such case the hospital authority shall be liable to repay ‘to the Commonwealth any amount which is found to have been overpaid when the amount actually payable in respect of that period is ascertained.

(6.) Payment shall be made to an approved hospital authority which is the proprietor of a private hospital at which a pharmaceutical chemist is employed at the rates which are applicable to the supply of pharmaceutical benefits by an approved pharmaceutical chemist at the place at which the hospital is situated.

(7.) Payment shall be made to an approved hospital authority which is the proprietor of a private hospital at which a pharmaceutical chemist is not employed at a rate equivalent to the wholesale cost of the pharmaceutical benefits supplied at the hospital (including the cost of transportation of the pharmaceutical benefits from the wholesale supplier to the place at which the hospital is situated).

Prescriptions not. to be written in certain cases.

33. A medical practitioner treating a person in or at an approved public hospital shall not write a prescription in accordance with Form E in respect of that treatment.

Parting with possession of forms, &c.

34.—(1.) A person shall not, except in accordance with the Act or these Regulations or with the consent or at the direction of the Director-General, part with possession of, mutilate or destroy—

(a) any copy of the Commonwealth Pharmaceutical Formulary, or of the addendum thereto;

(b)any copy of any rules; or

(c)any list or form,

supplied to him by or on behalf of the Commonwealth under or for the purposes of the Act or these Regulations.

(2.) The Director-General may, by notice in writing served on a person, require that person to deliver up to the Director-General, or to a person specified in the direction, within a time specified in the direction, any document or other paper specified in the last preceding sub-regulation which is in the possession of the person on whom the notice is served, and that person shall comply with the direction.

Penalty: Fifty pounds.

Service of notices, &c.

35. A notice or other document under the Act or these Regulations may be served by post on the person or authority to whom it is addressed at any premises in respect of which he or it is approved for the purposes of the Act or at his or its last known place of business or practice.

Use of old forms.

36.—(1.) Where the Commonwealth supplies a form which is substantially in accordance with a form prescribed by these Regulations, except that it bears a reference or references to the Pharmaceutical Benefits Act 1944, or to that Act as amended, that form may be used for the purposes of these Regulations as if it were in accordance with the prescribed form to which it substantially corresponds, and these Regulations shall apply in relation to that form as if it were in accordance with that prescribed form.

(2.) The provisions of these Regulations relating to copies of the Commonwealth Pharmaceutical Formulary supplied by the Commonwealth shall apply also in relation to copies of any formulary supplied by the Commonwealth for the purposes of the Act, including copies bearing a reference to the Pharmaceutical Benefits Act 1944, or to that Act as amended.

THE SCHEDULES.

FIRST SCHEDULE.

Reg. 5. Form A.

Commonwealth of Australia.

Pharmaceutical Benefits Act 1947.

APPLICATION FOR APPROVAL AS A PHARMACEUTICAL CHEMIST

(By a Registered Pharmacist or Pharmaceutical Chemist).

I 

We, 

(Name in full.)

of 

(Address.)

trading as 

hereby apply for approval as a pharmaceutical chemist under Pharmaceutical Benefits Act 1947, in respect of premises situated at

I	hereby declare that		I am a	pharmacist(s)	registered as // such under
We			we are	pharmaceutical chemist(s)
the law of the		State of
		Territory
I	further declare that		I am a	prepared to supply on demand, at the address specified
We			we are

above, pharmaceutical benefits in accordance with the Pharmaceutical Benefits Act 1947 and the Regulations thereunder.

Dated this day of 19 .

(Signature of Applicant)

To the Director-General of Health,

Commonwealth of Australia.

Note.—If approval is desired in respect of more than one premises, a separate application must be made in respect of each premises.

This form should be used, with necessary modifications, for the purposes of an application by the legal personal representative of a deceased pharmaceutical chemist.

First Schedule—continued.

Reg. 5. Form B.

Commonwealth op Australia.

Pharmaceutical Benefits Act 1947.

APPLICATION TOR APPROVAL AS A PHARMACEUTICAL CHEMIST.

(By a Friendly Society, &c.).

(Name of Friendly Society, &c.)

hereby applies for approval as a pharmaceutical chemist under the Pharmaceutical Benefits Act 1947, in respect of premises situated at

The said

(Name of Friendly Society, &c.)

18 prepared to supply on demand, at the address stated above, pharmaceutical benefits in accordance with the Pharmaceutical Benefits Act 1947 and the Regulations thereunder.

I,

(Name and address of person authorized to make application)

declare that 1 am authorized to make this application on behalf of the said

(Name of Friendly Society, &c.)

* And I further declare that the said friendly society was carrying on the business of a pharmaceutical chemist on the first day of August, 1945.

Dated this day of 19 .

(Signature of person authorized to make application)

To the Director-General of Health,

Commonwealth of Australia.

Note.—If approval is desired in respect of more than one premises, a separate application must be made in respect of each premises.

* Strike out if Inapplicable.

Reg. 5. Form C.

Commonwealth of Australia.

Pharmaceutical Benefits Act 1947.

APPLICATION FOR APPROVAL AS A HOSPITAL AUTHORITY.

(Name of hospital authority.)

being the	governing body	of the
	proprietor
a			Public	hospital,
			Private

(Name and address of hospital)

hereby applies in accordance with section 12 of the Pharmaceutical Benefits Act 1947 for approval to supply pharmaceutical benefits.

The said hospital authority is prepared to supply pharmaceutical benefits in accordance with the Pharmaceutical Benefits Act 1947 and the Regulations thereunder.

I,

(Name and address of person authorized to make application)

declare that I am authorized to make this application on behalf of the said hospital authority.

The name of the person who will dispense/supply pharmaceutical benefits on behalf of the said hospital authority is

His qualifications are

Dated this day of 19 .

(Signature of person authorised to make application)

To the Director-General of Health,

Commonwealth of Australia.

Note.—A separate application must be made in respect of each hospital governed by the same hospital authority in respect of which approval is sought.

First Schedule—continued.

Reg. 6. Form D

TRADING HOURS.

This pharmacy is open during the following hours:—

Week-days	a.m.	to	p.m.
Saturdays	a.m.	to	p.m.
Sundays	.m.	to	.m.
Holidays	.m.	to	.m.

EMERGENCY SERVICE.

A registered pharmacist is in attendance during the following hours: —

Week-days	p.m.	to	.m.
Saturdays	p.m.	to	.m.
Sundays	.m.	to	.m.
Holidays	.m.	to	.m.

Reg. 11. Form E

Commonwealth of Australia.

Pharmaceutical Benefits Act 1947.

PRESCRIPTION FORM.

Name

Address

Date

N.B.—One Formulary item only to be written on this Form, and title of the pharmaceutical benefits, as shown in the Commonwealth Pharmaceutical Formulary, to be indicated.

R

(Signature of Medical Practitioner)

(Address)

First Schedule—continued.

Reg. 14. Form F.

Commonwealth of Australia.

Pharmaceutical Benefits Act 1947.

STATEMENT MADE IN ACCORDANCE WITH SECTION 8 (3.) OF THE ACT.

(To be completed by the person presenting the prescription.)

I,

(Name in full)

of

(Address in full)

do solemnly and sincerely declare that, to the best of my knowledge and better, the prescription No.

presented on behalf of

and purporting to be signed by [Name and address of person signing prescription] has been signed by a registered or licensed medical practitioner and has not been forged or fraudulently obtained.

(Signature of person making statement)

(Signature of witness)

(Date)

Reg. 15. Form G.

Pharmaceutical Benefits Act 1974.

RECEIPT FOR REPEATED PRESCRIPTION.

I certify that 1 have this day received from the undermentioned chemist a repetition of prescription No.

(Signature)

(Address)

(Date)

(Name of chemist)

Reg. 17. Form H.

Commonwealth of Australia.

Pharmaceutical Benefits Regulations.

CERTIFICATE UNDER REGULATION 17.

1 hereby certify that

(Name of patient in full)

of

(Address of patient)

is in need of prolonged treatment, and has accordingly been directed by me to continue the treatment prescribed in the attached prescription No. for a period of weeks. I estimate that the

total	* number of doses	required during the period indicated herein will be *doses./ounces
	quantity

(Signature of medical practitioner)

(Dated)

* Strike out whichever is inapplicable. Internal remedies are to be stated in doses and external remedies in ounces.

First Schedule—continued.

Reg. 28. Form 1

Commonwealth of Australia.

Pharmaceutical Benefits Act 1947.

CERTIFICATE OF ANALYSIS.

I,

of

being an analyst duly appointed by the Director-General of Health to make analyses for the purposes of the Pharmaceutical Benefits Act 1947, do hereby certify that I received on the

day of , 19

(a) a sealed sample bearing the Mark No. ; and

(b)a copy of a prescription bearing the Mark No. , or order, and stamped with the name of

I further certify that I have analysed the said sample and I hereby declare that the results of my analysis are as follows:—

General Data.

(a) Nature of sample

(b)Net weight or volume of sample received

(c) Total fluid capacity of container (if sample is a fluid)

Particular Data.

Ingredients and quantities thereof as specified by the prescription referred to above.			Result of analysis.
Ingredients.	Total quantities prescribed.	Percentage which each ingredient constitutes of total weight or volume prescribed.	Total quantities of ingredients present in sample received.	Percentage which each ingredient show in Column 4 constitutes of total weight or volume of sample indicated under (b) above.	Percentage excess or deficit (if any).	Total quantities of ingredients estimated to be present in total volume of liquid dispensed as indicated by mark on container.
(1)	(2)	(3)	(4)	(5)	(6)	(7)

 

Additional Data.

 (Signature of Analyst)

(Date)

The Director-General of Health,

Canberra, A.C.T.

SECOND SCHEDULE.

Reg. 4.

COMMONWEALTH PHARMACEUTICAL FORMULARY.

In this formulary—

“fluid ounce” means 480 minims;

“ounce” means 437.5 grains.

The use in this formulary in relation to any item or part of an item of the letters “B.P.”, “B.P.C.” or “A.P.F.” indicates that that item or part of an item must conform to the requirements of the British Pharmacopoeia, the British Pharmaceutical Codex or the Australian Pharmaceutical Formulary, as the case may be.

Prescription Code.	—
1. GENERAL SECTION. Auristillae.
Ear Drops.
AC 1	Auristillae Acidi Borici (Aurist. Acid. Boric.)	Approximate Percentage.
Boric Acid................................................. 10 gr.	5
Glycerin..................................................... 60 min.
Industrial Methylated Spirit to 1/2 fl. oz.+
2	Auristillae Acidi Salicyuci (Aurist. Acid. Salicyl.)
Salicyclic Acid............................................. 4 gr.	2
Industrial Methylated Spirit......................... 90 min.
Distilled Water................................... to  1/2 fl. oz.+
3	Auristillae Chlorbutolis Oleosae (Aurist. Chlorbutol. Oleos.)
Chlorbutol.................................................. 6 gr.	3
Arnolds Oil........................................ to  1/2 fl. oz.+
4	Auristillae Hydrooenii Peroxidi (Aurist. Hydrogen. Perox.)
Solution of Hydrogen Peroxide................... 10 vols
1/2 fl. oz.+
5	Auristillae Ichthammolls (Aurist. Ichtham.)
Ichthammol................................................ 22 gr.	10
Glycerin............................................ to  1/2 fl. oz.+
6	Auristille Phenazoni (Aurist. Phenazon.)	6
Phenazone................................................. 10 gr.
Glycerin............................................ to  1/2 fl. oz.+
7	Auristillae Phenolis (Aurist. Phenol.)
Glycerin of Phenol..................................... 60 min.
Glycerin............................................ to  1/2 fl. oz.+
8	Auristillae Proflavinae (Aurist. Proflavin.)
Proflavine Sulphate.................................... 1/2 gr.	0.25
Sodium Bicarbonate................................... 1/8 gr.
Water................................................ to  1/2 fl. oz.+
9	Auristillae Proflavinae Spiritcosae (Aurist. Proflavin. Spirit.)
Proflavine Sulphate.................................... 1/2 gr.	0.25
Industrial Methylated Spirit......................... 180 min.
Water................................................ to  1/2 fl. oz.+
10	Auristillae Sodii Bicarbonate (Aurist. Sod. Bicarb.)
Sodium Bicarbonate................................... 8 gr.	4
Glycerin..................................................... 180 min.
Water................................................ to  1/2 fl. oz.+

 

Prescription Code.		—
Approximate Percentage.
11	Auristillae Spiritus (Altrist. Spirit.)
Industrial Methylated Spirit ..........  180 min.	70
Water........................................... to 1/2 fl. oz.+
12	Auristillae Violae Crystallinae (Aurist. Viol. Cryst.)
Crystal Violet B.P.C..................... 2 gr.	1
Industrial Methylated Spirit.......... 120 min.
Distilled Water......................... to  12 fl. oz.+
Capsulae.
Capsules.
Capsular Carbonei Tetrachloridi (Cap. Carbon. Tetrachlor.)
CP	1	+4 Caps.	Carbon Tetrachloride............................... 5 min. (0.3 mil.)
2	4 Caps.	Carbon Tetrachloride............................. 10 min. (0.0 mil.)
3	4-4 Caps	Carbon Tetrachloride............................. 15 min. (1 mil.)
Capsular Filicls (Cap. Filic.)
4	+8 Caps.	Extract of Male Fern............................... 5 min. (0.3 mil.)
5	+8 Caps.	Extract of Male Fern.............................. 10 min. (0.6 mil.)
6	+8 Caps.	Extract of Male Fern.............................. 15 min. (1 mil.)
Capsulae Olei Chenopodh (Cap. (U. Chenopod.)
7	+ 3 Caps.	Oil of Chenopodium................................ 5 min. (0.3 mil.)
8	+3 Caps.	Oil of Chenopodium.............................. 10 min. (0.6 mil.)
9	+ 3 Caps.	Oil of Chenopodium.............................. 15 min. (1 mil.)
Capsulae Tetrachlorethyleni (Cap. Tetrarhlorethylen.)
10	+ 12 Caps.	Tetrachlorethylene B.P.C......................... 5 min. (0.3 mil.)
11	+ 12 Caps	Tetrnchlorethylene B.P.C....................... 10 min. (0.6 mil.)
12	+ 12 Caps.	Tetrachlorethylene B.P.C....................... 15 min. (1 mil.)
Cataplasmata.
Poultices.
Cataplasma Kaolini B.P. 1032 (Cataplasm. Kaolin.)
CA	I	1/2 lb.	Kaolin Poultice
2	+ 1 lb.	Kaolin Poultice
Collodia.
Collodions.
CD	1	Collodium Acidi Salicylici (Collod. Acid. Salicyl.)
Salicylic Acid............................................ 15 gr.
Flexible Collodion......................... to  120 min.+
Collyria.
Eye Lotions.
CY	1	Collyrium Acidi Borici (Collyr. Acid. Boric.)
Boric Acid................................................. 90 gr.
Distilled Water.................................... to  6 fl. oz.+
2	Collyrium HydrarGyri Oxycyanidi Boricum (Collyr. Hydrarg. Oxycyanid. Boric.)
Mercuric Oxycyanide.................................. 1 gr.	0.04
Boric Acid................................................. 80 gr.
Distilled Water....................................... to  6 fl. oz.+

Second Schedule—continued.

Prescription Code.
CY	3	Collyrium Hydraroyri Perchloridi (Collyr. Hydrary. Perchlor.)
Solution of Mercuric Chloride.................... 1 fl. oz.
Distilled Water............................. to  6 fl. oz. +
4	Collyrium Sodii Bicarbonatis (Collyr. Sod. Bicarb.)
Sodium Bicarbonate................................... 120 gr.
Distilled Water............................. to  6 fl. oz.+
6	Collyrium Zinci Boricum (Collyr. Zinc. Boric.)
Zinc Sulphate.............................................. 6 gr.
Boric Acid................................................. 30 gr.
Chlorbutol Water A.P.F.  to  6 fl. oz.+
Conspersus.
Dusting Powders.
CS	1	Conspersus Benzocainae (Conspers. Benzocain.)
Benzocaine............................................... 22 gr.
Zinc Oxide................................................ 60 gr.
Starch.......................................... to  1/2 oz.+
2	Conspersus Chlorbutolis Compositus (Conspers. Chlorbutol. Co.
+2 oz.	Menthol...................................................... 2 gr.
Camphor................................................... 20 gr. Chlorbutol................................................. 45 gr.
Zinc Oxide................................................ 1/4 oz.
Starch.......................................... to  1 oz.
3	Conspersus Kaolini (Conspers. Kaolin.)
+2 oz.	Light Kaolin.............................................. 1/2 oz.
Zinc Oxide................................................ 1/4 oz.
Talc............................................. to  1 oz.
4	Conspersus Salicylicus (Conspers Salicyl.)
+2 oz.	Salicylic Acid............................................ 20 gr.
Starch......................................................... 1/4 oz.
Zinc Oxide.................................................. 1/4 oz.
Talc............................................. to  1 oz.
5	Conspersus Tannicus Compositus (Conspers. Tannic. Co.)
+1 oz.	Tannic Acid.............................................. 12 gr.
Salicylic Acid............................................ 12 gr.
Zinc Oxide................................................ 1/4 oz.
Starch........................................................ to 1 oz.
6	Conspersus Zinci Compositus (Conspers. Zinc. Co.)
+1 oz.	Starch........................................................ 1/4 oz.
Zinc Oxide................................................ 1/4 oz.
Talc............................................. to  1 oz.
Cremores.
Creams.	Approximate Percentage.
CR	1	Cremor Aminoacridinae (Crem. Aminoacridin.)
+1 oz.	Aminoacridine Hydrochloride A.P.F. ........... 0.44 gr.	0.1
Glyceryl Monostearate .............................. 40 gr.
Chlorocresol..............................................  0.44 gr.
Distilled Water............................. to  1 oz.

Second Schedule—continued.

Prescription Code.
Approximate Percentage.
CR	2	Cremor Aquosum (Crem. Aquos.)
+ 2 oz.	Borax......................................................... 5 gr. Water........................................................ 96 min. White Beeswax......................................... 80 gr. Arachis Oil................................... to  1 oz.
3	+2 oz.	Cremor Glycerini A.P.F. (Crem. Glycerin.)
4	Cremor Penicillini B.P. (Crem. Penicil.)
+½ oz.	Penicillin............................................... 500 units per gram.
5	Cremob Penicillini Sterilisatus B.P. (Crem. Penicil. Steril)
+½ oz.	Penicillin............................................... 500 units per gram.
6	Cremor Potassae Sulphuratae Composites A.P.F. (Crem. Pot. Sulphurat. Co.)

+4 oz.	Synonyms. Danish Cream, Marcussen’s Cream.
7	Cremor Proflavinae Sulphatis (Crem. Proflavin. Sulph.)
+1 oz.	Proflavine Sulphate.................................... 0.44 gr. Sodium Bicarbonate................................... 0.11 gr. Glyceryl Monostearate............................. 40 gr. Chlorocresol.............................................. 0.44 gr. Distilled Water............................. to  1 oz.	0.1
8	+4 oz.	Cremor Zinci A.P.F. (Crem. Zinc.)
8a	Any one of the following drugs may be prescribed with Cremor Zinci. The quantity indicated in each case is the maximum which may be added :—
8b 8c 8d 8e 8f 8g	Ammoniated Mercury................................ 10 gr. in 1 oz.  2.5 Brilliant Green B.P.C................................... 4 gr. „ ,,  „ 1 Crystal Violet B.P.C..................................... 4 gr.  „ ,, „   1 Ichthammol................................................. 20 gr. „ ,, „  5 Menthol....................................................... 10 gr.  „  „  „  2.5 Phenol......................................................... 10 gr.  „  „  „  2.5 Solution of Coal Tar..................................... 10 min. „   „  2.5
9	+4 oz.	CREMOR Zinci Molle (Crem. Zinc. Moll.)
Zinc Cream A.P.F...................................... 1 oz. Light Liquid Paraffin.................... to  1 fl. oz.
Elixiria.
Elixirs.
EL	1	+1 fl. oz.	Elixir Casoarae Sagradae B.P. (Elix. Case. Sag.)
2	+ 6 fl. oz.	Elixir Glycerophosphatum Compositum A.P.F. (Elix. Glycerophos. Co.)
2a	Allowable addition— Potassium Bromide.................................... Not exceeding 10 gr. in  60 minims.
Enemata.
Enemas.
EN	1	Enema Acidi Tannici (Enem. Acid. Tannic.)
Tannic Acid.............................................. 40 gr. Water........................................... to  1 fl. oz.+

Second Schedule—continued.

Prescription Code.
EN	2	Enema Fellis Bovini (Enem. Fell. Bon.)
Extract of Ox Bile...................................... 1 oz. Water........................................... to  2 fl. oz.+
3	Knema Opii (Enem. Opii.)
Synonym: Starch and Opium Enema.
Tincture of Opium..................................... 20 min. Starch in Powder....................................... 32 gr. Boiling Water............................... to  2 fl. oz.+
4	Enema Terebinthinae (Enem. Terebinth.)
Oil of Turpentine....................................... 1/2 fl. oz. Arachis Oil................................................ 1 fl. oz. Soft Soap.................................................. 1 oz. Warm Water................................. to  4 fl. oz.+
Gargarismata.
Gargles.
GA	1	Gargarisma Boracis Composita (Garg. Boracis Co.)
Borax........................................................ 60 gr. Sodium Bicarbonate................................... 60 gr. Liquefied Phenol....................................... 10 min. Glycerin.................................................. 120 min. Water........................................... to  4 fl. oz.+
2	Gargarisma Hydrargyri Perchloridi (Garg. Hydrarg. Perchlor.)
Solution of Mercuric Chloride........................ 1 fl. oz. Glycerin.................................................... 120 min. Water........................................... to  4 fl. oz.+
3	Gargarisma Hydrogenii Peroxidi (Garg. Hydrogen. Perox.)
Solution of Hydrogen Peroxide................... 10 vols. 4 fl. oz.+
4	Gargarisma Potassii Chloratis (Garg. Pot. Chlorat.)
Potassium Chlorate................................... 40 gr. Glycerin................................................... 1/2 fl. oz. Water........................................... to  4 fl. oz.+ Gelatina. Gelatins.
GE	1	+1 lb.	Gelatinum Zinci B.P. (Gelat Zinc.) Synonym :—Unna’s Paste. Glycantha. Glycantha.
GL	1	+½fl.oz.	Glycanthum A.P.F. (Glycanth.)
2	Glycanthum Acidi Tannici (Glycanth. Acid. Tannic.)
+2 fl. oz.	Tannic Acid.............................................. 10 gr. Glycanth A.P.F............................. to  1/2 fl. oz.
3	Glycanthum Acidi Tannici et Proflavinae (Glycanth. Acid. Tannic. et Proflavin.)
+2 fl. oz.	Tannic Acid............................................... 44 gr. Proflavine Sulphate.................................... 1/4 gr. Glycanth A.P.F............................. to  1/2 fl. oz.

Second Schedule—continued.

Prescription Code.
GL	4	Glycanthum Adrenalinae (Glycanth. Adrenalin.)
Solution of Adrenaline Hydrochloride 1 in 1,000  60 min. Glycanth A.P.F............................. to  1/2 fl. oz.+
5	Glycanthum Ephedrinae (Glycanth. Ephedrin.)
Ephedrino Hydrocholride .............................  2 gr. Glycanth A.P.F............................. to  1/2 fl. oz.+
6	Glycanthum Oxycyanidi (Glycanth. Oxycyan.)
Mercuric Oxycyanide................................... 1/2 gr. Glycanth A.P.F............................. to  1/2 fl. oz.+
7	Glycanthum Proflavinae (Glycanth. Proflavin.)
Proflavine Sulphate.................................... 1/4 gr. Glycanth A.P.F............................. to  1/2 fl. oz.+
8	Glycanthum Sulphonamidorum (Glycanth. Sulphonamid.)
Sulphanilamide............................................ 24 gr. Sulphamerazine........................................... 24 gr. Glycanth A.P.F............................. to  1/2 fl. oz.+
9	Glycanthum Violae Crystallinae (Glycanth. Crystal. Viol.)
Crystal Violet B.P.C..................................... 2 gr. Glycanth A.P.F............................. to  1/2 fl. oz.+
Guttae Ophthalmicae.
Eye Drops.
GO	1	Guttae Aroenti Nitratis (Gutt. Argent. Nil.) Silver Nitrate............................................... 1/2 gr. Distilled Water............................. to  120 min.+
2	Guttae Argenti Proteinatis 10% (Gutt. Argentoprol. 10%) Mild Silver Proteinato B.P.C........................ 10 gr. Distilled Water............................. to  120 min.+
3	Guttae Aroenti Proteinatis 20% (Gutt. Argentoprot. 20%)
Mild Silver Proteinate B.P.C......................... 20 gr. Distilled Water............................. to  120 min.+
4	Guttae Atropinae Sulphatis 1% (Gutt. Alrop. Sulph. 1%)
Atropine Sulphate........................................ 1 gr. Chlorbutol Water A.P.F. .............. to  120 min.+
5	Guttae Atropinae Sulphatis 2% (Gutt. Atrop. Sulph. 2%)
Atropine Sulphate.......................................... 2 gr. Chlorbutol Water A.P.F................ to  120 min.+
6	Guttae Cocainae et Adrenalinae (Gutt. Cocain. et Adrenalin.)  Synonym. Guttae B.C.A.
Cocaine Hydrochloride................................. 1/2 gr. Boric Acid................................................... 3 gr.
Solution of Adrenaline Hydrochloride 1 in 1,000 10 min. Chlorbutol Water A.P.F................ to  120 min.+
7	Guttae Cocainae, Adrenalinae et Zinci (Gutt. Cocain. Adrenalin, et Zinc.)
Synonym. Guttae B.C.A.Z.
Zinc Sulphate.............................................. 1/2 gr.
Cocaine and Adrenaline Eye Drops C.P.F............................................ to  120 min.+

Second Schedule—continued.

Prescription Code.		—
GO	8	Guttae Cocainae Oleosae (Gutt, Cocain. Oleos.)
Cocaine....................................................... 2½ gr. Castor Oil........................................ to  120 min.+
9	Guttae Homatropinae (Gutt Homatropin.)
Homatropine Hydrobromide......................... 1 gr. Chlorbutol Water A.P.F.................... to  120 min.+
10	Guttae Homatropinae et Cocainae (Gutt, Homatrop. et Cocain.)
Homatropine Hydrobromide......................... 1 gr. Cocaine Hydrochloride................................ 1 gr. Chlorbutol Water A.P.F.................... to  120 min.+
11	Guttae Hyoscinae 0.5% (Gutt. Hyoscin. 0.5%)
Hyoscine Hydrobromide.............................. 1/2 gr. Chlorbutol Water A.P.F.................... to  120 min.+
12	Guttae Hyoscinae 1% (Gutt. Hyoscin. 1%)
Hyosoine Hydrobromide............................ 1 gr. Chlorbutol Water A.P.F.  to  120 min.+
13	Guttae Phyhostiominae (Gutt. Physostigmin.)
Phyeoatigmine Salicylate............................. 1 gr. Chlorbutol Water A.P.F.................... to  120 min.+ Salieylale or Sulphate may be used.
14	Guttae Pilocarpinae (Gutt.Pilovarpin.)
Pilocarpine Nitrate....................................... 1 gr. Chlorbutol Water A.P.F.................... to  120 min.+
15	Guttae Proflavinae (Gutt. Proflavin.)
Proflavine Sulphate.................................... 1/20 gr. Sodium Bicarbonate................................... 1/20 gr. Distilled Water................................. to  120 min+
16	Guttae Sulphaoetamaid Solubilis (Gutt. Sulphacetamid. Solub.)
Soluble Sulphacetamide B.P....................... 12 gr. Distilled Water................................. to  120 min.+
17	Guttae Violae Crystallinae (Gutt. Viol. Crystal.)
Crystal Violet B.P.C.................................. 1/10 gr. Distilled Water................................. to  120 min.+
18	Guttae Zinci Sulphatis (Gutt. Zinc. Sulph.)
Zinc Sulphate.............................................. 1/2 gr. Chlorbutol Water A.P.F.................... to  120 min.+
Inhalationes.
Inhalations.
IN	1	Inhalatio Amylis Nitritis (Inhal. Amyl. Nitrit.)
+3 Caps.	Capsule of Amyl Nitrite............................... 3 min
2	Inhalatio Benzoino et Mentholis (Inhal. Benz. et Menthol.)
Menthol.................................................... 10 gr. Compound Tincture of Benzoin.................. 1/2 fl. oz. Industrial Methylated Spirit to.................... 1 fl. oz.+

Second Schedule—continued.

Prescription Code.
IN	3	Inhalatio Eucalypti et Pini (Inhal. Eucalypt. et Pini)
Oil of Eucalyptus....................................... 20 min.
Oil of Pine................................................. 20 min.
Light Magnesium Carbonate...................... 30 gr.
Water................................................. to  1 fl. oz.+
4	Inhalatio Mentholis et Eucalypti (Inhal. Menthol. et Eucalypt.)
Menthol...................................................... 6 gr.
Oil of Eucalyptus....................................... 40 min.
Industrial Methylated Spirit to....................... 1/2 fl. oz.+
Injectiones.
Injections.
A. Hypodermic Tablets.
B. Ampoules or Vials.
C. Rectal.
D. Sclerosing.
Hypo. Tabs.	A. HYPODERMIC TABLETS.
Hypodermic Tablet of Atropine Sulphate.
HT	1	+20	H.T. Atropine Sulphate.............................. 1/200 gr.
2	+20	H.T. Atropine Sulphate.............................. 1/150 gr.
3	+20	H.T. Atropine Sulphate.............................. 1/120 gr.
4	+20	H.T. Atropine Sulphate.............................. 1/100 gr.
Hypodermic Tablet of Emetine Hydrochloride.
5	+20	H.T. Emetine Hydrochloride...................... 1/2 gr.
Hypodermic Tablet of Hyoscine Hydrobromide.
6	+10	H.T. Hyoscine Hydrobromide..................... 1/150 gr.
7	+10	H.T. Hyoscine Hydrobromide..................... 1/120 gr.
8	+10	H.T. Hyoscine Hydrobromide..................... 1/100 gr.
Hypodermic Tablet of Hyoscine, Morphine and Atropine.
H.T. Hyoscin. Co....................................... Strength (A)—
Hyoscine Hydrobromide....................................... 1/100 gr.
Morphine Sulphate............................................... 1/6 gr.
9	+5	Atropine Sulphate................................................. 1/180 gr. H.T. Hyoscin. Co. Strength (B)—
Hyoscine Hydrobromide....................................... 1/100 gr.
Morphine Sulphate............................................... 1/4 gr.
10	+5	Atropine Sulphate................................................. 1/150 gr.
Hypodermic Tablet of Morphine Sulphate or Hydr ciiloride.
11	+20	H.T. Morphine Sulphate........................................ 1/12 gr.
12	+20	H.T. Morphine Sulphate........................................ 1/8 gr.
13	+20	H.T. Morphine Sulphate........................................ 1/6 gr.
14	+20	H.T. Morphine Sulphate........................................ 1/4 gr.
15	+20	H.T. Morphine Sulphate........................................ 1/2 gr.
Hypodermic Tablet of Morphine and Atropine.
H.T. Morph. et Atrop. Strength (A)—
Morphine Sulphate............................................... 1/8 gr.
16	+20	Atropine Sulphate................................................. 1/150 gr.
H.T. Morph. et Atrop. Strength (B)—
Morphine Sulphate............................................... 1/6 gr.
17	+20	Atropine Sulphate................................................. 1/150 gr.

Second Schedule—continued.

Prescription Code.
Hypo. Tabs.	H.T. Morph. et Atrop.................................. Strength (C)—
Morphine Sulphate................................................... 1/4 gr.
HT	18	+20	Atropine Sulphate................................................. 1/150 gr.
H.T. Morph. et Atrop. Strength (D)—
Morphine Sulphate................................................... 1/6 gr.
19	+20	Atropine Sulphate................................................. 1/100 gr.
H.T. Morph. et Atrop. Strength (E)
Morphine Sulphate................................................... 1/4 gr.
20	+20	Atropine Sulphate................................................. 1/100 gr.
Hypodermic Tablet of Morphine, Strychnine and Atropine.
H.T. Morph, titrych. ct Atropin. Strength (A)—
Morphine Sulphate................................................... 1/8 gr. Strychnine Sulphate................................................ 1/40 gr.
21	+20	Atropine Sulphate................................................. 1/240 gr.
H.T. Morph., Strych. ct Atropin. Strength (B)— Morphine Sulphate.................................................. 1/0 gr. Strychnine Sulphate............................................... 1/30 gr.
22	+20	Atropine Sulphate................................................. 1/200 gr.
H.T. Morph., Strych. et Atropin. Strength (C)—
Morphine Sulphate.................................................. 1/4 gr. Strychnine Sulphate............................................... 1/20 gr.
23	+20	Atropine Sulphate................................................. 1/200 gr.
Hypodermic Tablet of Papaverine and Morphine Compound.
24	+20	H.T. Papaverinae et Morphinae. Co.
Morphine Hydrochloride........................................ 16 gr.
Codeine Hydrochloride......................................... 1/12 gr.
Papaverine Hydrochloride..................................... 1/20 gr.
Narcotine Hydrochloride....................................... 1/20 gr.
B. AMPOULES AND VIALS.
Injectio Adrenalinae Hydrochloridi 1 in 1,000 (Inj. Adrenalin 1/1,000)
Solution of Adrenaline Hydrochloride—
IJ	1	+1 vial	1 in 1,000............................................................ 80 min. (5 mil.) Solution of Adrenaline Hydrochloride—
2	+1 vial	1 in 1,000............................................................ 160 min. (10 mil.)
Injectio Aneurinae Hydrochloridi (Inj. Aneurin. Hydrochlor.) Synonym. Injection of Vitamin B1.
3	+3 amps.	Aneurine Hydrochloride (I.M.)........................... 1/6 gr. (10 mg.) per mil.  in 1 mil. amp.
4	+1 via)	Aneurine Hydrochloride (I.M.)........................... 1/6 gr. (10 mg.) per mil. in 5 mil. rubber capped vial.
5	+3 amps.	Aneurine Hydrochloride (I.M.)........................... 5/6 gr. (50 mg.) per mil. in 1 mil. amp.
6	+1 vial	Aneurine Hydrochloride (I.M.)........................... 5/6 gr. (50 mg.) per mil. in 5 mil. rubber capped vial.
Injectio Bismuthi Salicylatis B.P.
7	+1 vial	(Inj. Bismuth. Salicyl.).................. 1 fl. oz. (30 mil.) in rubber capped vial.
Injectio Calcii Gluconatis B.P. (Inj. Calc. Gluconat.)
8	+3 amps.	Calcium Gluconate 10% Solution........................ 75 min. (5 mil.)
9	+3 amps.	Calcium Gluconate 10% Solution....................... 150 min. (10 mil.)

Second Schedule—continued.

Preacription Code.		—
Injectio Desoxycorticosteronis Acetatis.
Synonym. Injection of Decortone.
IJ	10	+4 amps.	Deoxycorticosterone Acetate...................... 1/12 gr. (5 mg.)
11	+4 amps.	Desoxycorticosterone Acetate...................... 1/6 gr. (10 mg.)
Injectio Dextrosi (Inj. Dextros.)
12	+1 amp.	Dextrose 50% Solution............................. 1 2/3 fl. oz. (50 mil.)
Injectio Diethylamini Acetarsolis (Inj. Diethylamin. Acetarsol.)
Intramuscular Injection—
13	+1 amp.	Children—Amp. of 2 mil. equiv. to 0.04 G. of As.
14	+1 amp.	Adults—Amp. of 3 mil. equiv. to 0.15 G. of As.
15	+1 amp.	Amp. of 5 mil. equiv. to 0.25 G. of As.
Injectio Digoxini (Inj. Digoxin.)
16	+1 amp.	Digoxin..................................................... 1/120 gr. (0.5 mg.)
Injectio Ergometrinae (Inj. Ergometrin.)
17	+1 amp.	Ergometrine (I.V.)..................................... 1/480 gr. (0.125 mg.)
18	4-1 amp.	Ergometrine (I.M.)..................................... 1/120 gr. (0.5 mg.) Injectio Hepatih (Inj. Hepat.)
19	+1 amp.	Injection of Liver (1 mil. = 125 G. fresh liver)........... 2 mil. amp.
20	+1 amp.	Injection of Liver (1 mil. = 250 G. fresh liver)........... 2 mil. amp.
21	+1 amp.	Injection of Liver (1 mil. = 250 G. fresh liver)........... 5 mil. amp.
22	+1 vial	Injection of Liver (1 mil. = 250 G. fresh liver).......... 10 mil. vial

C1
LZ 1........................................	100................................	H2
LZ 2........................................	50..................................	F1
LZ 3........................................	25..................................	E1
UG 1.......................................	1 oz..............................	C2	N, Q, W
UG 2.......................................	1 oz.............................	C3
UG 3.......................................	1 oz.............................	E1
UG 4.......................................	1 oz.............................	C2	N, W
UG 5.......................................	4 oz.............................	D2
UG 5.......................................	3 oz.............................	D1
UG 5.......................................	2 oz.............................	C3	N
UG 5.......................................	1 oz.............................	C2	N, W
UG 6.......................................	1 oz.............................	C3	N
UG 7.......................................	1 oz.............................	C3	N
UG 8.......................................	1 oz.............................	C3
UG 9.......................................	½ oz............................	D1
UG 10.....................................	4 oz.............................	D3
UG 10.....................................	3 oz.............................	D1	N, S, W
UG 10.....................................	2 oz.............................	D1
UG 10.....................................	1 oz.............................	C2	N, Q, W
UG 11.....................................	1 oz.............................	D1
UG 12.....................................	1 oz.............................	C3
UG 13.....................................	1 oz.............................	D1
UG 14.....................................	1 oz.............................	C3
UG 15.....................................	1 oz.............................	C3	N, W
UG 16.....................................	1 oz.............................	C3
UG 17.....................................	1 oz.............................	C2	N, W
UG 18.....................................	1 oz.............................	C2	N, W
UG 19.....................................	2 oz.............................	F2
UG 19.....................................	1 oz.............................	D2
UG 20.....................................	1 oz.............................	C3	N, W
UG 21.....................................	1 oz.............................	C3	N, Q, W
UG 22.....................................	1 oz.............................	D1
UG 23.....................................	1 oz.............................	C2	N, W
UG 24.....................................	1 oz.............................	C2	N, Q, W
UG 25.....................................	1 oz.............................	C3
UG 26.....................................	1 oz.............................	C3	N
UG 27.....................................	4 oz.............................	D2
UG 27.....................................	3 oz.............................	D1
UG 27.....................................	2 oz.............................	C3
UG 27.....................................	1 oz.............................	C2	N, W
UG 28.....................................	1 oz.............................	E1

Table B—continued.

Column 1.	Column 2.	Column 3.	Column 4.
Prescription Code.	Quantity or Number.	Price Group.	States in Which Price Group in to be raised.
UG 29.....................................	1 oz.............................	C3
UG 30.....................................	1 oz.............................	D3
UG 30.....................................	3 oz.............................	D2
UG 30.....................................	2 oz.............................	D1
UG 30.....................................	1 oz.............................	C3
UG 31.....................................	1 oz.............................	C2
UG 32.....................................	1 oz.............................	C2	N
UG 33.....................................	1 oz.............................	E2
UG 34.....................................	4 oz.............................	D1	N, W
UG 34.....................................	3 oz.............................	D1
UG 34.....................................	2 oz.............................	C3
UG 34.....................................	1 oz.............................	C2
UG 35.....................................	4 oz.............................	D1	N, Q, S, W
UG 35.....................................	3 oz.............................	D1
UG 35.....................................	2 oz.............................	C3
UG 35.....................................	1 oz.............................	C2
UG 36.....................................	1 oz.............................	C3
UG 37.....................................	2 oz.............................	E2	N, Q, S, W
UG 37.....................................	1 oz.............................	D2
UG 38.....................................	4 oz.............................	D1	N, W
UG 38.....................................	3 oz.............................	D1
UG 38.....................................	2 oz.............................	C3
UG 38.....................................	1 oz.............................	C2
UG 38a...................................	1 oz.............................	D2
UG 38a...................................	3 oz.............................	D1
UG 38a...................................	2 oz.............................	C3
UG 38a...................................	1 oz.............................	C2	N, W
UG 38b...................................	4 oz.............................	D2
UG 38b...................................	3 oz.............................	D1
UG 38b...................................	2 oz.............................	C3	N, W
UG 38b...................................	1 oz.............................	C2	N, W
UG 38c...................................	4 oz.............................	D1	N, W
UG 38c...................................	3 oz.............................	D1
UG 38c...................................	2 oz.............................	C3
UG 38c...................................	1 oz.............................	C2
UG 38d...................................	4 oz.............................	D1	N, S, W
UG 38d...................................	3 oz.............................	D1
UG 38d...................................	2 oz.............................	C3
UG 38d...................................	1 oz.............................	C3
UG 39.....................................	1 oz.............................	D1	N
UG 39.....................................	3 oz.............................	D1
UG 39.....................................	2 oz.............................	C3
UG 39.....................................	1 oz.............................	C2
LC 1........................................	2 fl. oz.........................	C1	S, W
MC 1.......................................	2 fl. oz.........................	C1
MC 2.......................................	2 fl. oz.........................	C1
MC 3.......................................	2 fl. oz.........................	C1
MC 4.......................................	2 fl. oz.........................	C1
MC 5.......................................	2 fl. oz.........................	B3	S, W
MC 6.......................................	2 fl. oz.........................	C1
MC 7.......................................	2 fl. oz.........................	C1
MC 8.......................................	2 fl. oz.........................	B3
MC 9.......................................	2 fl. oz.........................	C1
MC 10.....................................	2 fl. oz.........................	C1
MC 11.....................................	2 fl. oz.........................	C1
MC 12.....................................	4 fl. oz.........................	C2	N, Q, S, W
MC 13.....................................	2 fl. oz.........................	B3	N, V, S, W, T

Table B—continued.

Column 1.	Column 2.	Column 3.	Column 4.
Prescription Code.	Quantity or Number.	Price Group.	States in which Price. Group is to be raised.
MC 14....................................	2 fl. oz.........................	D2
MC 15....................................	2 fl. oz.........................	B3
MC 16....................................	1 fl. oz.........................	B3
MC 17....................................	2 fl. oz.........................	C1
MC 18....................................	2 fl. oz.........................	C1
MC 19....................................	2 fl. oz.........................	C1
MC 20....................................	2 fl. oz.........................	C1
MC 21....................................	2 fl. oz.........................	C2
MC 22....................................	6 fl. oz.........................	C2
MC 23....................................	16 fl. oz.........................	F3	S, w
MC 23....................................	9 fl. oz.........................	E1	W
MC 23....................................	6 fl. oz.........................	D2
MC 24....................................	1 fl. oz.........................	B3
MC 25....................................	1 fl. oz.........................	B3
MC 20....................................	16 fl. oz.........................	F3	W
MC 20....................................	9 fl. oz.........................	E1
MC 20....................................	6 fl. oz.........................	D2
MC 27....................................	2 fl. oz.........................	C2
MC 28....................................	2 fl. oz.........................	C1
MC 29....................................	2 fl. oz.........................	C1
MC 30....................................	2 fl. oz.........................	C1
MC 31....................................	2 fl. oz.........................	C1
MC 32....................................	2 fl. oz.........................	B3	S, W
SC 1.......................................	2 fl. oz.........................	C3	N, V, S, W, T
SC 2.......................................	4 fl. oz.........................	C3
SC 3.......................................	1 fl. oz.........................	C1
VM 1......................................	120 mins.........................	E2
VM 2......................................	120 mins.........................	D1
VM 3......................................	120 mins.........................	D2
BA 1.......................................	3.................................	SG8
BA 1.......................................	2.................................	SG9
BA 1.......................................	1.................................	V2
BA 2.......................................	1.................................	D1
BA 3.......................................	1.................................	SG10
BA 4.......................................	1.................................	J2
BA 5.......................................	1.................................	M1
BA 6.......................................	1.................................	O1
BA 7.......................................	1.................................	SG87
BA 8.......................................	5.................................	SG11
BA 8.......................................	4.................................	SG12
BA 8.......................................	3.................................	SG13
BA 8.......................................	2.................................	SG14
BA 8.......................................	1.................................	SG15
BA 9.......................................	10.................................	SG16
BA 9.......................................	9.................................	SG8
BA 9.......................................	8.................................	SG17
BA 9.......................................	7.................................	SG18
BA 9.......................................	6.................................	SG9
BA 9.......................................	5.................................	SG19
BA 9.......................................	4.................................	SG20
BA 9.......................................	3.................................	V2
BA 9.......................................	2.................................	O3
BA 9.......................................	1.................................	H1
BA 10.....................................	1.................................	K1
BA 11.....................................	10.................................	SG21
BA 11.....................................	9.................................	SG22

Table B—continued.

Column 1.	Column 2.	Column 3.	Column 4.
Prescription Code.	Quantity or Number.	Price Group.	States in which Price Group is to be raised.
BA 11..........................................	8.................................	SG23
BA 11..........................................	7.................................	SG14
BA 11..........................................	6.................................	SG24
BA 11..........................................	7.................................	SG25
BA 11..........................................	4.................................	SG26
BA 11..........................................	3.................................	SG8
BA 11..........................................	2.................................	SG9
BA 11..........................................	1.................................	V2
BA 12..........................................	1.................................	M1
BA 13..........................................	10................................	SG27
BA 13..........................................	9.................................	SG28
BA 13..........................................	8.................................	SG29
BA 13..........................................	7.................................	SG30
BA 13..........................................	6.................................	SG31
BA 13..........................................	5.................................	SG24
BA 13..........................................	4.................................	SG32
BA 13..........................................	3.................................	SG33
BA 13..........................................	2.................................	SG34
BA 13..........................................	1.................................	SG88
BA 14..........................................	10................................	SG35
BA 14..........................................	9.................................	SG32
BA 14..........................................	8.................................	SG36
BA 14..........................................	7.................................	SG37
BA 14..........................................	6.................................	SG38
BA 14..........................................	5.................................	SG17
BA 14..........................................	4.................................	SG39
BA 14..........................................	3.................................	SG40
BA 14..........................................	2.................................	SG89
BA 14..........................................	1.................................	M1
BA 15..........................................	1.................................	SG90
BA 16..........................................	3.................................	SG41
BA 16..........................................	2.................................	SG42
BA 16..........................................	1.................................	SG91
BA 17..........................................	1.................................	C2
BA 18..........................................	1.................................	E2
BA 19..........................................	1.................................	F3
BA 20..........................................	1.................................	SG87
BA 21..........................................	1.................................	SG20
BA 22..........................................	2.................................	SG16
BA 22..........................................	1.................................	SG19
BB 1............................................	1.................................	C2
BB 2............................................	1.................................	C2
BB 3............................................	1.................................	C2
BB 4............................................	1.................................	C2
BB 5............................................	1.................................	D1
BB 6............................................	5.................................	SG92
BB 6............................................	4.................................	O3
BB 6............................................	3.................................	L2
BB 6............................................	2.................................	H1
BB 6............................................	1.................................	D3
BB 7............................................	1 tube..........................	B3
BC 1............................................	1 set............................	E1
BC 2............................................	2.................................	H1
BC 2............................................	1.................................	D3
BC 3............................................	1.................................	C2

Table B—continued

Column 1.	Column 2.	Column 3.	Column 4.
Prescription Code.	Quantity or Number.	Price Group.	States in which Price Group is to be raised.
BD 1.........................................	6.................................	SG43
BD 1.........................................	5.................................	SG44
BD 1.........................................	4.................................	SG45
BD 1.........................................	3.................................	SG46
BD 1.........................................	2.................................	SG47
BD 1.........................................	1.................................	SG48
BD 2.........................................	6.................................	SG49
BD 2.........................................	5.................................	SG50
BD 2.........................................	4.................................	SG51
BD 2.........................................	3.................................	SG52
BD 2.........................................	2.................................

SG53
BD 2.........................................	1.................................	8G54
BD 3.........................................	6.................................	SG55
BD 3.........................................	5.................................	SG56
BD 3.........................................	4.................................	SG52
BD 3.........................................	3.................................	SG57
BD 3.........................................	2.................................	J2
BD 3.........................................	1.................................	SG58
BD 4.........................................	6.................................	SG59
BD 4.........................................	5.................................	8G60
BD 4.........................................	4.................................	SG61
BD 4.........................................	3.................................	SG62
BD 4.........................................	2.................................	SG63
BD 4.........................................	1.................................	SG64
BD 4.........................................	6.................................	SG65
BD 5.........................................	5.................................	SG66
BD 5.........................................	4.................................	SG67
BD 5.........................................	3.................................	SG59
BD 5.........................................	2.................................	8G61
BD 5.........................................	1.................................	SG63
BD 6.........................................	1.................................	B3
BD 7.........................................	1.................................	C2
BD 8.........................................	1.................................	C2
BD 9.........................................	1.................................	D2
BD 10.......................................	100................................	B2
BD 10.......................................	50................................	B2
BD 10.......................................	25................................	B1
BD 11.......................................	100................................	B2
BD 11.......................................	50................................	B2
BD 11.......................................	25................................	B1
BD 12.......................................	100................................	B2
BD 12.......................................	50................................	B2
BD 12.......................................	25................................	B1
BD 13.......................................	100................................	B2
BD 13.......................................	50................................	B2
BD 13.......................................	25................................	B1
BD 14.......................................	100................................	B2
BD 14.......................................	50................................	B2
BD 14.......................................	25................................	B1
BD 15.......................................	100................................	B2
BD 15.......................................	50................................	B2
BD 15.......................................	25................................	B1
BD 16.......................................	100................................	B3
BD 16.......................................	50................................	B2
BD 16.......................................	25................................	B1	N, W
BD 17.......................................	100................................	C1
BD 17.......................................	50................................	B3
BD 17.......................................	25................................	B2
BD 18.......................................	100................................	C3
BD 18.......................................	50................................	C1
BD 18.......................................	25................................	B3

Table B—continued.

Column 1.	Column 2.	Column 3.	Column 4.
Prescription Code.	Quantity or Number.	Price Group.	States in which Price Group is to be raised.
BE 1........................................	1 bottle...........................	E2
BE 2........................................	1 bottle...........................	L2
BF 1........................................	1.....................................	C2
BF 2........................................	1.....................................	B3
BF 3........................................	1.....................................	E2
BF 4........................................	1.....................................	H1
BF 5........................................	1.....................................	B3
BF 6........................................	1.....................................	E2
BF 7........................................	1.....................................	H1
BF 8........................................	1.....................................	B3
BF 9........................................	1.....................................	E2
BF 10......................................	1.....................................	H1
BF 11......................................	1.....................................	B3
BF 12......................................	1.....................................	E2
BF 13......................................	1.....................................	H1
BF 14......................................	1.....................................	B3
BF 15......................................	1.....................................	E2
BF 16......................................	1.....................................	H1
BF 17......................................	1.....................................	B3
BF 18......................................	1.....................................	E2
BF 19......................................	1.....................................	H1
DS 1........................................	1.....................................	SG47
DS 2........................................	1.....................................	H1
DS 3........................................	1.....................................	SG68
DS 4........................................	1.....................................	SG68
DS 5........................................	1.....................................	SG69
DS 6........................................	1.....................................	SG70
DS 7........................................	1.....................................	SG68
DS 8........................................	1.....................................	SG71
DS 9........................................	1.....................................	SG72
DS 10......................................	1.....................................	SG73
DS 11......................................	1.....................................	EI
DS 12......................................	1.....................................	SG74
DS 13......................................	1.....................................	C3
DS 14......................................	1.....................................	SG75
DS 15......................................	1.....................................	SG10

       

By Authority : L. F. JOHNSTON, Commonwealth Government Printer, Canberra.,